2015
Association Between Radiation Dose and Outcomes With Postoperative Radiation Therapy for N0-N1 Non-Small Cell Lung Cancer
Wang E, Corso C, Park H, Chen A, Kim A, Wilson L, Decker R, Yu J. Association Between Radiation Dose and Outcomes With Postoperative Radiation Therapy for N0-N1 Non-Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e387-e388. DOI: 10.1016/j.ijrobp.2015.07.1536.Peer-Reviewed Original ResearchAssociation between radiation dose and outcomes with postoperative radiotherapy for N0-N1 non-small-cell-lung cancer.
Wang E, Corso C, Park H, Chen A, Kim A, Wilson L, Decker R, Yu J. Association between radiation dose and outcomes with postoperative radiotherapy for N0-N1 non-small-cell-lung cancer. Journal Of Clinical Oncology 2015, 33: 7538-7538. DOI: 10.1200/jco.2015.33.15_suppl.7538.Peer-Reviewed Original Research
1992
Tempol, a stable free radical, is a novel murine radiation protector.
Hahn S, Tochner Z, Krishna C, Glass J, Wilson L, Samuni A, Sprague M, Venzon D, Glatstein E, Mitchell J. Tempol, a stable free radical, is a novel murine radiation protector. Cancer Research 1992, 52: 1750-3. PMID: 1551104.Peer-Reviewed Original ResearchConceptsWhole-body radiationRadiation protectorsVivo radioprotective effectsHypoxic cell radiosensitizersDose of radiationRadiation-induced cytotoxicityTempol treatmentControl micePotential therapeutic applicationsC3H miceBlood 5Hypoxanthine/xanthine oxidaseRadioprotective effectSignificant radioprotectionTempolMiceHypoxic radiosensitizationXanthine oxidaseDoseTherapeutic applicationsCellular levelCultured cellsFree radicalsRadioprotectionWhole animal